RGC

Regencell Bioscience Holdings Ltd

RGC, USA

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

https://www.regencellbioscience.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
RGC
stock
RGC

Why Regencell Bioscience Shares Keep Sliding Now TipRanks

Read more →
RGC
stock
RGC

Regencell Bioscience (NASDAQ:RGC) Trading Down 7.8% - What's Next? MarketBeat

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3,310.65

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-35.61 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-30.07 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.18

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.22% of the total shares of Regencell Bioscience Holdings Ltd

1.

Geode Capital Management, LLC

(0.0791%)

since

2025/06/30

2.

Fidelity Nasdaq Composite Index

(0.0593%)

since

2025/07/31

3.

Fidelity Nasdaq Composite ETF

(0.0242%)

since

2025/08/29

4.

Squarepoint Ops LLC

(0.0202%)

since

2025/06/30

5.

Schonfeld Strategic Advisors LLC

(0.0105%)

since

2025/06/30

6.

BNP Paribas Arbitrage, SA

(0.0091%)

since

2025/06/30

7.

UBS Group AG

(0.0076%)

since

2025/06/30

8.

Morgan Stanley - Brokerage Accounts

(0.0067%)

since

2025/06/30

9.

Y-Intercept (Hong Kong) Ltd

(0.0026%)

since

2025/06/30

10.

Greenfield Savings Bank

(0.0022%)

since

2025/06/30

11.

BlackRock Inc

(0.0017%)

since

2025/06/30

12.

Advisor Group Holdings, Inc.

(0%)

since

2025/06/30

13.

Bank of America Corp

(0%)

since

2025/06/30

14.

Citigroup Inc

(0%)

since

2025/06/30

15.

Royal Bank of Canada

(0%)

since

2025/06/30

16.

Tower Research Capital LLC

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2026-03-31

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0

EPS Estimate

0

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(0.5)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(2.5)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.